Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann R Coll Surg Engl ; 103(6): 452-458, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33851890

RESUMO

INTRODUCTION: Several treatment modalities have been postulated to improve the efficacy of varicose vein treatment. Addition of glycerine to the sclerosing material has been documented to increase its viscosity and subsequently prolong the duration of stability, in addition to the direct sclerosing effect of glycerine. This histological and immunohistochemical study investigated the efficacy of addition of glycerine 72% to sclerotherapy on the human varicose vein. METHODS: After surgical stripping of great saphenous veins, three equal segments were resected between two clamps. Specimen 1 was injected with saline only, specimen 2 was exposed to foam sclerosant 2%, and specimen 3 was exposed to a mixture of foam sclerosant 2% and glycerine 72%. All segments were left for 5min. Vein segments were then processed for histological and immunohistochemical study. RESULTS: Microscopically, haematoxylin and eosin-stained specimen 1 showed endothelial swelling, cytoplasmic eosinophilia and pyknotic nuclei. The media showed sarcoplasm vacuolisation and necrosis. Specimen 3 showed hypereosinophilic sarcoplasm of the smooth muscle fibres. Oedema was less evident, with a relative decrease in the thickness of the wall compared with specimen 2. Immunohistochemically, the expression of smooth muscle actin was weak in specimen 3 compared with specimens 1 and 2. Expression of CD31 antibody was much reduced in specimen 2 which showed conserved islands of endothelial cells. By contrast, there was a complete loss of endothelial cells in specimen 3. CONCLUSION: Addition of glycerine 72% to foam sclerosant has a more damaging effect on human vein wall.


Assuntos
Edema/patologia , Glicerol/farmacologia , Polidocanol/farmacologia , Veia Safena/patologia , Soluções Esclerosantes/farmacologia , Actinas/metabolismo , Combinação de Medicamentos , Endotélio/efeitos dos fármacos , Endotélio/metabolismo , Endotélio/patologia , Glicerol/uso terapêutico , Humanos , Imuno-Histoquímica , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/metabolismo , Músculo Liso Vascular/patologia , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Polidocanol/uso terapêutico , Veia Safena/efeitos dos fármacos , Veia Safena/metabolismo , Soluções Esclerosantes/uso terapêutico , Varizes/terapia , Viscosidade
2.
Biophys Chem ; 80(1): 31-40, 1999 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-10457595

RESUMO

The effects of type-I collagen on dipalmitoyl phosphatidylcholine (DPPC) and dimyristoyl phosphatidylcholine (DMPC) monolayer films with different compositions were studied using monolayer technique. The addition of collagen in the subphase of different monolayer films induced a considerable shift towards larger area/molecule in the compression-isotherm curves. This is either referred to the insertion of collagen into the monolayer by its hydrophobic residues or to an adsorption process causing a protein layer to be located parallel to the lipid monolayer [1]. The variation of collagen interaction with different lipid compositions was also verified through the penetration-kinetics experiment. Comparing our results to the results of Pajean et al. [2] and Pajean and Herbage [3] on the effect of collagen on the stability of lipid vesicles implies that the collagen induced stability could be explained on the basis of collagen-lipid monolayer interaction.


Assuntos
Colágeno/química , Fosfolipídeos/química , 1,2-Dipalmitoilfosfatidilcolina/química , Materiais Biocompatíveis/química , Fenômenos Biofísicos , Biofísica , Fenômenos Químicos , Físico-Química , Dimiristoilfosfatidilcolina/química , Sistemas de Liberação de Medicamentos , Estabilidade de Medicamentos , Termodinâmica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...